Mercaptopurine and Blast cells present - a phase IV clinical study of FDA data

Summary:

Blast cells present is reported as a side effect among people who take Mercaptopurine (mercaptopurine), especially for people who are male, 60+ old, also take Jakafi, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Blast cells present when taking Mercaptopurine. It is created by eHealthMe based on reports of 22,744 people who have side effects when taking Mercaptopurine from the FDA, and is updated regularly.

What is Mercaptopurine?

Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 23,013 Mercaptopurine users. Check the latest studies of Mercaptopurine.

What is Blast cells present?

Blast cells present is found to be associated with 71 drugs and 113 conditions by eHealthMe. Check the latest studies of Blast cells present.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

22,744 people reported to have side effects when taking Mercaptopurine.
Among them, 13 people (0.06%) have Blast cells present.

Could Mercaptopurine cause Blast cells present?

Among these 13 people:

What is the gender of people who have Blast cells present when taking Mercaptopurine? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Blast cells present when taking Mercaptopurine? *

What are other drugs people take besides Mercaptopurine? *

Jakafi: 5 people, 38.46%
Methotrexate: 3 people, 23.08%
Zofran: 3 people, 23.08%
Norvasc: 2 people, 15.38%
Cipro: 2 people, 15.38%
Elidel: 2 people, 15.38%
Fluconazole: 2 people, 15.38%
Glycolax: 2 people, 15.38%
Heparin: 2 people, 15.38%
Hydrocodone Bitartrate And Acetaminophen: 2 people, 15.38%

What are other side effects people have besides Blast cells present? *

Central Nervous System Leukaemia (cancer of central nervous system): 5 people, 38.46%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 38.46%
Fever: 5 people, 38.46%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 30.77%
Thrombocytopenia (decrease of platelets in blood): 3 people, 23.08%
Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 3 people, 23.08%
Cranial Nerve Paralysis (loss of function of cranial nerve): 2 people, 15.38%
Leukoencephalopathy (disease of the white matter in the brain): 2 people, 15.38%
Leukocytosis (increased white blood cells): 2 people, 15.38%
Head Injury: 2 people, 15.38%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 46.15%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 15.38%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 7.69%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mercaptopurine and have Blast cells present?

- Check whether Blast cells present is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mercaptopurine:

Mercaptopurine (23,013 reports)

Browse all side effects of Mercaptopurine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blast cells present:

Blast cells present (71 drugs)

Browse all the conditions that are associated with Blast cells present:

Blast cells present (113 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mercaptopurine (the active ingredients of Mercaptopurine) and Mercaptopurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.